OCUGEN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 786.19K shares, a 415.07% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 422.85K shares, a 7549.20% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 17.32K shares.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 122.22K shares, a 4.72% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 297.70K shares, a 4.53% increase from fiscal 2024.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 284.79K shares, a 3.46% decline from fiscal 2023.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 295.00K shares.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 919.00 shares, a 87.74% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 786.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.35M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 422.85K shares 10-Q · filed 2026-05-08 | 715.02K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 17.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 297.70K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 122.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 280.38K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 152.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 274.87K shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 5.53K shares 10-Q · filed 2025-05-09 | 188.89K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | 284.79K shares 10-K · filed 2025-03-05 |
| 2024-09-30 | 116.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 339.79K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 66.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 223.08K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 101.43K shares 10-Q · filed 2024-05-14 | 196.43K shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 55.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 295.00K shares 10-K · filed 2024-04-16 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | |
| 2023-03-31 | 200.00K shares 10-Q · filed 2023-05-05 | |
| 2022-09-30 | 529.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2022-06-30 | 488.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | |
| 2022-03-31 | 277.32K shares 10-Q · filed 2022-05-06 | |
| 2021-09-30 | 232.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 919.00 shares 10-K · filed 2019-03-22 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 919.00 shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 8.42K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 919.00 shares 10-Q · filed 2018-05-10 | 8.42K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 7.50K shares 10-K · filed 2018-03-15 |
| 2017-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 7.50K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 2.75K shares derived: sum of 4 quarters · filed 2017-08-10 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-11 | 2.75K shares derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 3.69K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 2.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 3.69K shares derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 37.59K shares derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | 937.00 shares 10-Q · filed 2016-05-12 | 54.40K shares derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 53.46K shares 10-K · filed 2016-03-10 |
| 2015-09-30 | 36.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2015-06-30 | 16.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-14 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |